Metropolitan Life Insurance Company (MetLife)’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History
Bought
Maintained
Sold
Metropolitan Life Insurance Company (MetLife)'s RPTP Position: Q4 2016 in Review
Metropolitan Life Insurance Company (MetLife) sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q4 2016, closing a stake of 59,833 shares — an estimated $537K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in RPTP in Q2 2013 and held it in 14 quarters. The position peaked at $936K in Q2 2015. 0 funds tracked by Wall St. Rank hold RPTP as of Q4 2016.
- Metropolitan Life Insurance Company (MetLife) reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q4 2016 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 59,833 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q4 2016, an estimated $537K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2013 and held it in 14 quarters.
- Metropolitan Life Insurance Company (MetLife)'s RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $936K in Q2 2015.
- 0 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q4 2016.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2016, filed 14 Feb 2017.